Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Amino acid residues in the N-terminal of the PA subunit (PAN) of the Influenza A polymerase play critical roles in
endonuclease activity, protein stability and vRNA promoter binding. In addition, PAN is highly conserved among different
subtypes of the influenza virus, which suggests PAN to be a desirable target for the development of anti-influenza agents. We
selected DNA aptamers targeting the intact PA protein or the PAN
domain of an H5N1 virus strain using systematic evolution of
ligands by exponential enrichment (SELEX). Binding affinities of selected aptamers were measured, followed by evaluation of
in vitro endonuclease inhibitory activity. Next, antiviral effects of enriched aptamers against influenza A virus infections were
further examined. A total of three aptamers targeting PA and six aptamers targeting PAN were selected. Our data demonstrated
that all three PA-selected aptamers neither inhibited endonuclease activity nor exhibited antiviral efficacy, whereas four of the
six PAN-selected aptamers inhibited both endonuclease activity and H5N1 virus infection. These results suggested that PAN
functional domain might be a better target than the intact PA protein for the screening of antiviral agents. Among the four
effective aptamers, one exhibited cross-protection against infections of H1N1, H5N1, H7N7 and H7N9 influenza viruses with
50% inhibitory concentration (IC50) around 10 nM. Notably, this aptamer was identified at the 5th round but disappeared after
the 10th round of the selection, suggesting that the identification and evaluation of aptamers at early rounds of the selection
may be highly helpful for screening effective aptamers. Overall, our study provides novel insights for screening and developing
effective aptamers as anti-influenza drugs.